2005
DOI: 10.1182/blood-2005-03-1175
|View full text |Cite
|
Sign up to set email alerts
|

Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

12
186
3
27

Year Published

2006
2006
2016
2016

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 225 publications
(228 citation statements)
references
References 36 publications
12
186
3
27
Order By: Relevance
“…9 However, the results of the present study and other studies suggest that expression of neither FOXP1 nor Mum1/IRF4 has prognostic significance in the group of primary cutaneous large B-cell lymphoma, leg type. 24 In primary cutaneous follicle center lymphoma, an expression pattern similar to that of normal centrocytes and centroblasts was observed supporting their germinal center cell-origin. The tumor cells expressed early B-cell transcription factors Pax-5 and PU.1, germinal center marker Bcl-6, transcription factors Oct2 and BOB.1, but not the plasma cell and ABC markers Mum1/IRF4, Blimp-1 and FOXP1.…”
Section: Discussionmentioning
confidence: 81%
“…9 However, the results of the present study and other studies suggest that expression of neither FOXP1 nor Mum1/IRF4 has prognostic significance in the group of primary cutaneous large B-cell lymphoma, leg type. 24 In primary cutaneous follicle center lymphoma, an expression pattern similar to that of normal centrocytes and centroblasts was observed supporting their germinal center cell-origin. The tumor cells expressed early B-cell transcription factors Pax-5 and PU.1, germinal center marker Bcl-6, transcription factors Oct2 and BOB.1, but not the plasma cell and ABC markers Mum1/IRF4, Blimp-1 and FOXP1.…”
Section: Discussionmentioning
confidence: 81%
“…If a causal link between some cases of MF and Bb infection could be confirmed, a specific antibiotic therapy might be useful to improve the disease outcome even though MF is a T-cell lymphoma. In fact, there are already reports of primary cutaneous B-cell lymphomas responding to antibiotic therapy designed to treat Bb infection (Hofbauer et al, 2001) even though the findings about the association between Bb and B-cell lymphomas are controversial (Goodlad et al, 2000;Kodama et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…Approximately two-thirds of these lymphomas are of T-cell origin, and the pathogenesis and management of both T-and B-cell cutaneous lymphomas have been recently reviewed. [1][2][3][4][5][6] The most common form of cutaneous T-cell lymphoma (CTCL) is mycosis fungoides (MF), accounting for around 60% of new cases. SĂ© zary syndrome (SS) is much rarer and accounts for only 5% of CTCL cases.…”
Section: Introductionmentioning
confidence: 99%